Aemetis (NASDAQ:AMTX) Shares Pass Below 200 Day Moving Average of $4.34

Shares of Aemetis, Inc. (NASDAQ:AMTX) passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $4.34 and traded as low as $4.31. Aemetis shares last traded at $4.47, with a volume of 618,498 shares trading hands.

Analyst Ratings Changes

Several research firms recently issued reports on AMTX. Truist Financial cut their price objective on Aemetis from $5.00 to $3.50 and set a “hold” rating on the stock in a report on Tuesday, January 23rd. Stifel Nicolaus cut their price objective on Aemetis from $8.00 to $6.50 and set a “buy” rating on the stock in a report on Wednesday, February 21st.

Aemetis Stock Performance

The stock has a market capitalization of $190.46 million, a price-to-earnings ratio of -3.39 and a beta of 1.01. The company has a 50 day moving average of $4.05 and a 200 day moving average of $4.34.

Aemetis (NASDAQ:AMTX) last released its earnings results on Thursday, March 7th. The specialty chemicals company reported ($0.34) EPS for the quarter, topping the consensus estimate of ($0.35) by $0.01. The company had revenue of $70.76 million for the quarter, compared to analyst estimates of $80.08 million. During the same period in the previous year, the firm earned ($0.63) earnings per share. As a group, research analysts expect that Aemetis, Inc. will post -1.44 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the stock. Charles Schwab Investment Management Inc. boosted its position in shares of Aemetis by 3.1% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 75,306 shares of the specialty chemicals company’s stock worth $955,000 after acquiring an additional 2,254 shares in the last quarter. JPMorgan Chase & Co. boosted its position in shares of Aemetis by 16.0% during the 1st quarter. JPMorgan Chase & Co. now owns 16,362 shares of the specialty chemicals company’s stock worth $208,000 after acquiring an additional 2,256 shares in the last quarter. Guggenheim Capital LLC boosted its position in shares of Aemetis by 18.7% during the 3rd quarter. Guggenheim Capital LLC now owns 17,879 shares of the specialty chemicals company’s stock worth $110,000 after acquiring an additional 2,818 shares in the last quarter. Point72 Asset Management L.P. acquired a new position in shares of Aemetis during the 2nd quarter worth about $25,000. Finally, Tower Research Capital LLC TRC boosted its position in shares of Aemetis by 173.7% during the 3rd quarter. Tower Research Capital LLC TRC now owns 5,586 shares of the specialty chemicals company’s stock worth $34,000 after acquiring an additional 3,545 shares in the last quarter. 27.02% of the stock is owned by institutional investors and hedge funds.

About Aemetis

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the acquisition, development, and commercialization of negative carbon intensity products and technologies that replace traditional petroleum-based products.